Virtus ETF Advisers LLC Macrogenics Inc Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 19,694 shares of MGNX stock, worth $64,202. This represents 0.03% of its overall portfolio holdings.

Number of Shares

19,694

Previous 19,343 1.81%

Holding current value

$64,202

Previous $82,000 21.95%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $1,053 - $1,948	351 Added 1.81%	19,694 $64,000
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $33,212 - $185,729	10,034 Added 107.79%	19,343 $82,000
Q1 2024 May 15, 2024	SELL	$9.77 - $21.47 $6,203 - $13,633	-635 Reduced 6.39%	9,309 $137,000
Q4 2023 Feb 15, 2024	BUY	$4.48 - $10.11 $44,549 - $100,533	9,944 New	9,944 $95,000
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $21,501 - $95,464	-9,556 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $4,579 - $9,531	-564 Reduced 5.57%	9,556 $84,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $1,479 - $2,034	-93 Reduced 0.91%	10,120 $162,000
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $10,679 - $15,526	-541 Reduced 5.03%	10,213 $214,000
Q2 2021 Aug 10, 2021	SELL	$20.49 - $35.63 $38,808 - $67,483	-1,894 Reduced 14.97%	10,754 $289,000
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $4,348 - $7,602	229 Added 1.84%	12,648 $403,000
Q4 2020 Feb 12, 2021	SELL	$19.41 - $26.0 $57,550 - $77,090	-2,965 Reduced 19.27%	12,419 $284,000
Q3 2020 Nov 13, 2020	SELL	$24.69 - $31.6 $51,849 - $66,360	-2,100 Reduced 12.01%	15,384 $388,000
Q2 2020 Aug 05, 2020	SELL	$5.2 - $29.12 $85,586 - $479,286	-16,459 Reduced 48.49%	17,484 $488,000
Q1 2020 May 14, 2020	SELL	$4.28 - $12.11 $21,237 - $60,089	-4,962 Reduced 12.75%	33,943 $198,000
Q4 2019 Feb 13, 2020	BUY	$7.95 - $12.27 $177,372 - $273,755	22,311 Added 134.45%	38,905 $423,000
Q3 2019 Nov 12, 2019	SELL	$12.44 - $17.48 $11,507 - $16,169	-925 Reduced 5.28%	16,594 $212,000
Q2 2019 Aug 13, 2019	BUY	$14.51 - $19.71 $254,200 - $345,299	17,519 New	17,519 $297,000
Q1 2019 May 14, 2019	SELL	$11.11 - $25.6 $236,976 - $546,048	-21,330 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$11.75 - $21.42 $3,536 - $6,447	301 Added 1.43%	21,330 $271,000
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $289,689 - $352,861	-15,041 Reduced 41.7%	21,029 $451,000
Q2 2018 Aug 10, 2018	SELL	$19.78 - $24.67 $62,979 - $78,549	-3,184 Reduced 8.11%	36,070 $745,000
Q1 2018 May 14, 2018	BUY	$18.89 - $32.46 $400,411 - $688,054	21,197 Added 117.39%	39,254 $988,000
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $6,346 - $7,957	-392 Reduced 2.12%	18,057 $343,000
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $26,197 - $31,970	1,688 Added 10.07%	18,449 $341,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,761	16,761 $293,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Macrogenics Inc Transaction History